Temporary Closure – In-Service Training
ATTENTION: HealthWell Foundation’s hotline will be closed from 12:00 p.m. to 1:30 p.m. on Tuesday, October 3, 2023, due to in-service training for our staff. We encourage you to continue to use our Patient, Pharmacy and Provider Portals during this time. If you are contacting us about a payment or grant, please email us at grants@healthwellfoundation.org and a representative will respond to your message as quickly as possible when our hotline re-opens at 1:30 p.m. We apologize for any inconvenience and look forward to serving you. The HealthWell Team
Dismiss alert
Precision medicine – treatments that are based on an individual’s specific genetics and the cancer cell’s genes – holds great promise for lung cancer patients. For all patients, precision medicine is made possible through a type of advanced diagnostic testing called biomarker testing. However, for some racial and ethnic minorities,…more.
For this week’s post in our series on melanoma melanoma, Real World Health Care interviewed Kelly M. McMasters, MD, PhD. Dr. McMasters serves as the director of the Multidisciplinary Melanoma Clinic at the University of Louisville’s James Graham Brown Cancer Center. Here, he works with colleagues to identify the most…more.
Real World Health Care continues our series on melanoma with a discussion with Howard Kaufman, MD, FACS, surgical oncologist at Rutgers Cancer Institute of New Jersey. Dr. Kaufman’s clinical and research work focuses on using the immune system to fight cancer. He also runs a scientific laboratory focusing on oncolytic…more.
May is Melanoma awareness month, and our series on melanoma continues with a discussion with Dr. Douglas B. Johnson of the Vanderbilt-Ingram Cancer Center. Dr. Johnson leads Vanderbilt’s melanoma clinical and research program, overseeing clinical trials, patient care and translational research. His research interests focus on developing new immune and…more.
Real World Health Care concludes its series on non-small cell lung cancer by speaking with Erica Carpenter, MBA, PhD, Research Assistant Professor in the Department of Medicine at the Perelman School of Medicine at the University of Pennsylvania. Dr. Carpenter also serves as Director of the Circulating Tumor Material Laboratory…more.
Continuing our series on non-small cell lung cancer, this week Real World Health Care speaks with Lecia V. Sequist, MD, MPH, Associate Professor of Medicine at Harvard Medical School and the Mary B. Soltonstall endowed chair in oncology at Massachusetts General Hospital. Dr. Sequist’s research focuses on studying novel targets…more.
This week, Real World Health Care talks with Edward B. Garon, M.D., Associate Professor of Medicine at the David Geffen School of Medicine at UCLA Health. He specializes in hematology and oncology, with an interest in lung cancer and chest malignancies. Dr. Garon’s research focuses on the testing and development…more.
As part of our series on non-small cell lung cancer (NSCLC), Real World Health Care spoke with Hossein Borghaei, D.O., in the Department of Hematology/Oncology at Fox Chase Cancer Center, which is part of the Temple Health System. Dr. Borghaei serves as Chief, Thoracic Medical Oncology; Director, Lung Cancer Risk…more.
This week, Real World Health Care speaks with lung cancer specialist, Gregory Masters, MD, FASCO, attending physician at the Helen F. Graham Cancer Center and associate professor at the Thomas Jefferson University Medical School. In addition to being Fellow of the American Society for Clinical Oncology, Dr. Masters is co-chair…more.
As part of our series on non-small cell lung cancer (NSCLC), Real World Health Care spoke with Susan J. Rappaport, MPH, vice president for research and scientific affairs, American Lung Association. Rappaport provides leadership and direction in the development and implementation of the American Lung Association public health education and…more.
